ODTX
Odyssey Therapeutics, Inc.
20.99
+0.99 (+4.95%)
52w low 15.10
29.05 high
42.2% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Operating Cash Flow | -99.84M | -112.73M | -117.47M | -129.47M | |
| Depreciation & Amort | 2.76M | 4.91M | 5.19M | 4.91M | |
| Capital Expenditure | -13.03M | -5.06M | -764.00K | -1.23M | |
| Free Cash Flow | -112.87M | -117.78M | -118.23M | -130.70M | |
| Investing Cash Flow | -13.03M | -165.02M | 96.78M | -103.94M | |
| Financing Cash Flow | 182.72M | 92.08M | 26.98M | 215.65M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
-33.5%